國立虎尾科技大學 |

Adenosine receptors and Parkinson's disease

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Adenosine receptors and Parkinson's disease/ edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner.
other author:	Kase, Hiroshi.
Published:	San Diego, CA :Academic Press, : c2000.,
Description:	xviii, 275 p. [1] col. plate :ill. ; : 24 cm.;
Subject:	Parkinson's disease. -
Online resource:	An electronic book accessible through the World Wide Web; click for information
ISBN:	9780124004054

Adenosine receptors and Parkinson's disease
Adenosine receptors and Parkinson's disease[electronic resource] /edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner. - San Diego, CA :Academic Press,c2000. - xviii, 275 p. [1] col. plate :ill. ;24 cm. - Pure and applied mathematics series ;v. 90. - Pure and applied mathematics (Academic Press) ;60..

Includes bibliographical references and index.

H. Kase, Introductory Remarks: Adenosine A2A Receptor Antagonists: A Novel Approach to the Treatment of Parkinson's Disease. -- S.J. Augood, P.C. Emsom, and D.G. Standaert, Localisation of Adenosine Receptors in Brain and Periphery. -- J. Shimada and F. Suzuki, Medicinal Chemistry of Adenosine Receptors in Brain and Periphery. -- A. Karasawa, Overview of the Physiology and Pharmacology of Adenosine in the Peripheral System. -- H. Nonaka and M. Ichimura, Biochemical Characterizatoin of Adenosine Agonists and Antagonists. -- A. Mori and T. Shindou, Physiology of Adenosine Receptors in the Striatum: Regulation of Striatal Projection Neurons. -- P. Richardson and M. Kurokawa, The Regulation of Neurotransmitter Release in Basal Ganglia by Adenosine Receptor Agonists and Antagonists in Vitro and in Vivo. -- A. Dixon and P. Richardson, Control of Gene Expression in the Basal Ganglia Induced by Adenosine Receptors. -- S. Aoyama, J.-H. Baik, H. Kase, and E. Borrelli, Knockout Mice in the Study of Dopaminergic Diseases. -- S. Shiozaki, S. Ichikawa, J. Nakamura, and Y. Kuwana, Effects of Adenosine Receptors Experimental Models of Cognition and Motor Behaviour. -- T. Kanda and P. Jenner, Actions of Adenosine Antagonists in a Primate Model of Parkinson's Disease. -- A. Tahar, R. Grondin, L. Gregoire, A. Mori, H. Kase, and P.J. Bedard, Selective Adenosine A2A Receptor Antagonism as an Alternative Therapy for Parkinson's Disease: A Study in Nonhuman Primates. -- M. Nomoto, Neurobiology of Adenosine Receptors: Adenosine and its Metabolites in Movement Disorders.

This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2007.

Mode of access: World Wide Web.

ISBN: 9780124004054

Source: 79258:79258Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

582860
Parkinson's disease.
Index Terms--Genre/Form:

554714
Electronic books.

LC Class. No.: RC382 / .A34 2000eb

Dewey Class. No.: 616.8/33

National Library of Medicine Call No.: 2000 A-764

Adenosine receptors and Parkinson's disease
LDR:04221cam 2200361Ia 4500 001 679555
003 OCoLC
005 20110614113935.0
006 m d
007 cr cn|||||||||
008 111108s2000 cauaf ob 001 0 eng d
020 $a 9780124004054
020 $a 0124004059
029 1 $a NZ1 $b 12433376
029 1 $a AU@ $b 000042525355
035 $a (OCoLC)162574424
035 $a ocn162574424
037 $a 79258:79258 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS $d OCLCG $d OCLCQ
049 $a TEFA
050 1 4 $a RC382 $b .A34 2000eb
060 1 4 $a 2000 A-764
060 1 4 $a WL 359 $b A232a 2000
082 0 4 $a 616.8/33 $2 22
245 0 0 $a Adenosine receptors and Parkinson's disease $h [electronic resource] / $c edited by Hiroshi Kase, Peter J. Richardson, Peter Jenner.
260 $a San Diego, CA : $b Academic Press, $c c2000.
300 $a xviii, 275 p. [1] col. plate : $b ill. ; $c 24 cm.
490 1 $a Pure and applied mathematics series ; $v v. 90
504 $a Includes bibliographical references and index.
505 0 $a H. Kase, Introductory Remarks: Adenosine A2A Receptor Antagonists: A Novel Approach to the Treatment of Parkinson's Disease. -- S.J. Augood, P.C. Emsom, and D.G. Standaert, Localisation of Adenosine Receptors in Brain and Periphery. -- J. Shimada and F. Suzuki, Medicinal Chemistry of Adenosine Receptors in Brain and Periphery. -- A. Karasawa, Overview of the Physiology and Pharmacology of Adenosine in the Peripheral System. -- H. Nonaka and M. Ichimura, Biochemical Characterizatoin of Adenosine Agonists and Antagonists. -- A. Mori and T. Shindou, Physiology of Adenosine Receptors in the Striatum: Regulation of Striatal Projection Neurons. -- P. Richardson and M. Kurokawa, The Regulation of Neurotransmitter Release in Basal Ganglia by Adenosine Receptor Agonists and Antagonists in Vitro and in Vivo. -- A. Dixon and P. Richardson, Control of Gene Expression in the Basal Ganglia Induced by Adenosine Receptors. -- S. Aoyama, J.-H. Baik, H. Kase, and E. Borrelli, Knockout Mice in the Study of Dopaminergic Diseases. -- S. Shiozaki, S. Ichikawa, J. Nakamura, and Y. Kuwana, Effects of Adenosine Receptors Experimental Models of Cognition and Motor Behaviour. -- T. Kanda and P. Jenner, Actions of Adenosine Antagonists in a Primate Model of Parkinson's Disease. -- A. Tahar, R. Grondin, L. Gregoire, A. Mori, H. Kase, and P.J. Bedard, Selective Adenosine A2A Receptor Antagonism as an Alternative Therapy for Parkinson's Disease: A Study in Nonhuman Primates. -- M. Nomoto, Neurobiology of Adenosine Receptors: Adenosine and its Metabolites in Movement Disorders.
520 $a This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2007. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on Aug. 2, 2007). $n Access may be restricted to users at subscribing institutions.
650 0 $a Parkinson's disease. $3 582860
650 0 $a Adenosine $x Receptors. $3 583453
650 0 $a Adenosine $x Antagonists $x Therapeutic use. $3 788960
650 1 2 $a Parkinson Disease $x drug therapy. $3 788961
650 2 2 $a Receptors, Purinergic P1 $x antagonists & inhibitors. $3 788962
650 4 $a Adenosine. $3 788963
650 4 $a Parkinson's disease $x Treatment. $3 788964
655 4 $a Electronic books. $2 local $3 554714
700 1 $a Kase, Hiroshi. $3 788956
700 1 $a Richardson, Peter J. $3 788957
700 1 $a Jenner, Peter, $d 1946- $3 788958
710 2 $a ScienceDirect (Online service) $3 636041
830 0 $a Pure and applied mathematics (Academic Press) ; $v 60. $3 788959
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780124004054 $z An electronic book accessible through the World Wide Web; click for information
994 $a C0 $b TEF